UBS Group’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341M | Sell |
4,117,555
-3,083,227
| -43% | -$256M | 0.06% | 273 |
|
|
2025
Q1 | $584M | Buy |
7,200,782
+3,622,240
| +101% | +$294M | 0.11% | 158 |
|
|
2024
Q4 | $322M | Buy |
3,578,542
+1,819,814
| +103% | +$164M | 0.06% | 254 |
|
|
2024
Q3 | $174M | Buy |
1,758,728
+68,846
| +4% | +$6.8M | 0.04% | 358 |
|
|
2024
Q2 | $157M | Sell |
1,689,882
-206,347
| -11% | -$19.1M | 0.04% | 348 |
|
|
2024
Q1 | $180M | Sell |
1,896,229
-609,505
| -24% | -$57.8M | 0.04% | 308 |
|
|
2023
Q4 | $224M | Buy |
2,505,734
+785,800
| +46% | +$70.2M | 0.07% | 225 |
|
|
2023
Q3 | $126M | Buy |
1,719,934
+433,408
| +34% | +$31.6M | 0.04% | 316 |
|
|
2023
Q2 | $107M | Sell |
1,286,526
-64,869
| -5% | -$5.4M | 0.04% | 369 |
|
|
2023
Q1 | $103M | Buy |
1,351,395
+52,429
| +4% | +$4M | 0.04% | 359 |
|
|
2022
Q4 | $108M | Sell |
1,298,966
-1,369,407
| -51% | -$114M | 0.04% | 350 |
|
|
2022
Q3 | $212M | Sell |
2,668,373
-1,392,815
| -34% | -$110M | 0.09% | 180 |
|
|
2022
Q2 | $302M | Buy |
4,061,188
+1,968,451
| +94% | +$146M | 0.12% | 146 |
|
|
2022
Q1 | $188M | Sell |
2,092,737
-462,515
| -18% | -$41.6M | 0.06% | 238 |
|
|
2021
Q4 | $286M | Buy |
2,555,252
+1,085,449
| +74% | +$122M | 0.08% | 177 |
|
|
2021
Q3 | $185M | Sell |
1,469,803
-541,065
| -27% | -$68M | 0.06% | 250 |
|
|
2021
Q2 | $272M | Buy |
2,010,868
+64,554
| +3% | +$8.74M | 0.09% | 187 |
|
|
2021
Q1 | $264M | Sell |
1,946,314
-812,891
| -29% | -$110M | 0.09% | 175 |
|
|
2020
Q4 | $388M | Buy |
2,759,205
+475,393
| +21% | +$66.9M | 0.13% | 130 |
|
|
2020
Q3 | $254M | Buy |
2,283,812
+245,204
| +12% | +$27.3M | 0.1% | 168 |
|
|
2020
Q2 | $228M | Buy |
2,038,608
+77,409
| +4% | +$8.67M | 0.1% | 169 |
|
|
2020
Q1 | $152M | Sell |
1,961,199
-228,674
| -10% | -$17.7M | 0.07% | 207 |
|
|
2019
Q4 | $208M | Sell |
2,189,873
-41,500
| -2% | -$3.95M | 0.07% | 204 |
|
|
2019
Q3 | $170M | Sell |
2,231,373
-3,276,738
| -59% | -$250M | 0.07% | 224 |
|
|
2019
Q2 | $483M | Sell |
5,508,111
-2,646,440
| -32% | -$232M | 0.19% | 104 |
|
|
2019
Q1 | $738M | Buy |
8,154,551
+175,441
| +2% | +$15.9M | 0.31% | 60 |
|
|
2018
Q4 | $573M | Buy |
7,979,110
+4,988,385
| +167% | +$358M | 0.26% | 76 |
|
|
2018
Q3 | $287M | Sell |
2,990,725
-1,326,374
| -31% | -$127M | 0.11% | 154 |
|
|
2018
Q2 | $411M | Buy |
4,317,099
+2,041,371
| +90% | +$194M | 0.18% | 117 |
|
|
2018
Q1 | $200M | Sell |
2,275,728
-743,057
| -25% | -$65.2M | 0.09% | 188 |
|
|
2017
Q4 | $256M | Buy |
3,018,785
+1,434,097
| +90% | +$122M | 0.11% | 166 |
|
|
2017
Q3 | $137M | Sell |
1,584,688
-105,143
| -6% | -$9.1M | 0.06% | 222 |
|
|
2017
Q2 | $130M | Sell |
1,689,831
-1,973,852
| -54% | -$152M | 0.07% | 236 |
|
|
2017
Q1 | $254M | Buy |
3,663,683
+1,670,731
| +84% | +$116M | 0.14% | 149 |
|
|
2016
Q4 | $118M | Sell |
1,992,952
-589,377
| -23% | -$34.9M | 0.07% | 237 |
|
|
2016
Q3 | $171M | Buy |
2,582,329
+491,834
| +24% | +$32.6M | 0.1% | 182 |
|
|
2016
Q2 | $113M | Buy |
2,090,495
+219,558
| +12% | +$11.9M | 0.07% | 232 |
|
|
2016
Q1 | $96.7M | Sell |
1,870,937
-991,839
| -35% | -$51.2M | 0.06% | 246 |
|
|
2015
Q4 | $201M | Sell |
2,862,776
-707,647
| -20% | -$49.7M | 0.13% | 157 |
|
|
2015
Q3 | $222M | Buy |
3,570,423
+2,563,366
| +255% | +$160M | 0.16% | 129 |
|
|
2015
Q2 | $254M | Buy |
1,007,057
+97,321
| +11% | +$24.5M | 0.17% | 125 |
|
|
2015
Q1 | $205M | Buy |
909,736
+326,799
| +56% | +$73.7M | 0.14% | 151 |
|
|
2014
Q4 | $109M | Buy |
+582,937
| New | +$109M | 0.08% | 232 |
|